Integrase-RNA Interactions Underscore the Critical Role of Integrase in HIV-1 Virion

Total Page:16

File Type:pdf, Size:1020Kb

Integrase-RNA Interactions Underscore the Critical Role of Integrase in HIV-1 Virion bioRxiv preprint doi: https://doi.org/10.1101/2019.12.18.881649; this version posted December 19, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Integrase-RNA interactions underscore the critical role of integrase in HIV-1 virion 2 morphogenesis 3 4 Short title: Key role for HIV-1 integrase-RNA interactions in virion maturation 5 6 Jennifer Elliott1, Jenna E. Eschbach1, Pratibha C. Koneru2, Wen Li3,4, Maritza Puray 7 Chavez1, Dana Townsend1, Dana Lawson1, Alan N. Engelman3,4, Mamuka Kvaratskhelia2, 8 Sebla B. Kutluay1 9 10 1 Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, 11 MO 63110, USA 12 2 Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, CO 80045 13 3 Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 14 02215 15 4 Department of Medicine, Harvard Medical School, Boston, MA 02115 16 17 18 Correspondence: [email protected] 19 20 21 22 23 24 25 26 bioRxiv preprint doi: https://doi.org/10.1101/2019.12.18.881649; this version posted December 19, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 27 ABSTRACT 28 A large number of HIV-1 integrase (IN) alterations, referred to as class II substitutions, exhibit 29 pleotropic effects during virus replication. However, the underlying mechanism for the class II 30 phenotype is not known. Here we demonstrate that all tested class II IN substitutions 31 compromised IN-RNA binding in virions by one of three distinct mechanisms: i) markedly 32 reducing IN levels thus precluding formation of IN complexes with viral RNA; ii) adversely 33 affecting functional IN multimerization and consequently impairing IN binding to viral RNA; iii) 34 directly compromising IN-RNA interactions without substantially affecting IN levels or functional 35 IN multimerization. Inhibition of IN-RNA interactions resulted in mislocalization of the viral 36 ribonucleoprotein complexes outside the capsid lattice, which led to premature degradation of 37 the viral genome and IN in target cells. Collectively, our studies uncover causal mechanisms for 38 the class II phenotype and highlight an essential role of IN-RNA interactions for accurate virion 39 maturation. 40 41 INTRODUCTION 42 Infectious HIV-1 virions are formed in a multistep process coordinated by interactions 43 between the HIV-1 Gag and Gag-Pol polyproteins, and the viral RNA (vRNA) genome. At the 44 plasma membrane of an infected cell, Gag and Gag-Pol molecules assemble around a vRNA 45 dimer and bud from the cell as a spherical immature virion, in which the Gag proteins are 46 radially arranged [1-3]. As the immature virion buds, the viral protease enzyme is activated and 47 cleaves Gag and Gag-Pol into their constituent domains triggering virion maturation [1, 2]. 48 During maturation the cleaved nucleocapsid (NC) domain of Gag condenses with the RNA 49 genome and pol-encoded viral enzymes [reverse transcriptase (RT) and integrase (IN)] inside 50 the conical capsid lattice, composed of the cleaved capsid (CA) protein, which together form the 51 core [1-3]. 2 bioRxiv preprint doi: https://doi.org/10.1101/2019.12.18.881649; this version posted December 19, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 52 After infection of a target cell, RT in the confines of the reverse transcription 53 complex (RTC) synthesizes linear double stranded DNA from vRNA [4]. The vDNA is 54 subsequently imported into the nucleus, where the IN enzyme catalyzes its insertion into the 55 host cell chromosome [5, 6]. Integration is mediated by the intasome nucleoprotein complex that 56 consists of a multimer of IN engaging both ends of linear vDNA [7]. While the number of IN 57 protomers required for intasome function varies across Retroviridae, single particle cryogenic 58 electron microscopy (cryo-EM) structures of HIV-1 and Maedi-visna virus indicate that lentivirus 59 integration proceeds via respective higher-order dodecamer and hexadecamer IN arrangements 60 [8, 9], though a lower-order intasome comprised of an HIV-1 IN tetramer was also resolvable by 61 cryo-EM [9]. 62 A number of IN substitutions which specifically arrest HIV-1 replication at the integration 63 step have been described [10]. These substitutions are grouped into class I to delineate them 64 from a variety of other IN substitutions, which exhibit pleiotropic effects and are collectively 65 referred to as class II substitutions [10-12]. Class II IN substitutions or deletion of entire IN 66 impair proper particle assembly [11, 13-25], morphogenesis [11, 15, 21-23, 26-28] and reverse 67 transcription in target cells [10, 11, 17, 19-21, 23, 25-44], in some cases without impacting IN 68 catalytic function [15, 16, 19, 20, 30, 31, 34, 36, 45-47]. A hallmark morphological defect of 69 these viruses is the formation of aberrant viral particles with viral ribonucleoprotein (vRNP) 70 complexes mislocalized outside of the conical CA lattice [11, 15, 21-23, 26-28]. Strikingly similar 71 morphological defects are observed in virions produced from cells treated with allosteric 72 integrase inhibitors (ALLINIs, also known as LEDGINs, NCINIs, INLAIs or MINIs) [26, 27, 48- 73 55]. ALLINIs induce aberrant IN multimerization in virions by engaging the V-shaped pocket at 74 the IN dimer interface, which also provides a principal binding site for the host integration 75 targeting cofactor lens epithelium-derived growth factor (LEDGF)/p75 [50, 54, 56-60]. The 76 recent discovery that HIV-1 IN binds to the vRNA genome in virions and that inhibiting IN-RNA 3 bioRxiv preprint doi: https://doi.org/10.1101/2019.12.18.881649; this version posted December 19, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 77 interactions leads to the formation of eccentric particles provided initial clues about the role of IN 78 during virion morphogenesis [28]. 79 HIV-1 IN consists of three independently folded protein domains: the N-terminal domain 80 (NTD), catalytic core domain (CCD), and C-terminal domain (CTD) [7, 61], and vRNA binding is 81 mediated by a constellation of basic residues within the CTD [28]. However, class II IN 82 substitutions are located throughout the entire length of the IN protein [10, 12], which raises the 83 question as to how these substitutions impair virus maturation. The structural basis for IN 84 binding to RNA is not yet known; however, in vitro evidence indicates that IN binds RNA as 85 lower-order multimers, and conversely RNA binding may prevent the formation of higher order 86 IN multimers [28]. Notably, aberrant IN multimerization underlies the inhibition of IN-RNA 87 interactions by ALLINIs [28] and subsequent defects in virion maturation [26-28, 48, 49, 51-55]. 88 Therefore, it seems plausible that class II IN substitutions may exert their effect on virus 89 replication by adversely affecting functional IN multimerization. However, a systematical 90 evaluation of the effects of IN substitutions on IN multimerization, IN-RNA binding, and virion 91 morphology is lacking. As such, it remains an open question how functional IN multimerization 92 and/or IN-RNA interactions influence correct virion morphogenesis. 93 Eccentric virions generated via class II IN substitutions or ALLINI treatment are defective 94 for reverse transcription in target cells [10, 11, 17, 19-21, 23, 25-44, 48, 49, 51, 54, 58, 62] 95 despite containing equivalent levels of RT and vRNA genome as wild type (WT) particles [26, 96 63]. In addition, neither the condensation of the viral genome by NC [26, 63] nor its priming [63] 97 appear to be affected. We and others have recently shown that premature loss of the viral 98 genome and IN, as well as spatial separation of RT from vRNPs, may underlie the reverse 99 transcription defect observed in eccentric viruses generated in the presence of ALLINIs or the 100 class II IN R269A/K273A substitutions [59, 64]. These findings support a model in which the 101 capsid lattice or IN binding to vRNA itself is necessary to protect viral components from the host 4 bioRxiv preprint doi: https://doi.org/10.1101/2019.12.18.881649; this version posted December 19, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 102 environment upon entering a target cell. Whether the premature loss of the viral genome and IN 103 is a universal outcome of other class II IN substitutions is unknown. 104 In this work, we aimed to determine the molecular basis of how class II IN substitutions 105 exert their effects on HIV-1 replication. In particular, by detailed characterization of how class II 106 substitutions impact IN multimerization, IN-RNA interactions and virion morphology, we aimed to 107 dissect whether loss of IN binding to vRNA or aberrant IN multimerization underlies the 108 pleiotropic defects observed in viruses bearing class II IN mutations.
Recommended publications
  • Herpes Simplex Virus Type 1 Oril Is Not Required for Virus Infection In
    JOURNAL OF VIROLOGY, Nov. 1987, p. 3528-3535 Vol. 61, No. 11 0022-538X/87/113528-08$02.00/0 Copyright C 1987, American Society for Microbiology Herpes Simplex Virus Type 1 oriL Is Not Required for Virus Replication or for the Establishment and Reactivation of Latent Infection in Mice MARYELLEN POLVINO-BODNAR, PAULO K. ORBERG, AND PRISCILLA A. SCHAFFER* Laboratory of Tumor Virus Genetics, Dana-Farber Cancer Institute, and Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115 Received 11 May 1987/Accepted 31 July 1987 During the course of experiments designed to isolate deletion mutants of herpes simplex virus type 1 in the gene encoding the major DNA-binding protein, ICP8, a mutant, d61, that grew efficiently in ICP8-expressing Vero cells but not in normal Vero cells was isolated (P. K. Orberg and P. A. Schaffer, J. Virol. 61:1136-1146, 1987). d61 was derived by cotransfection of ICP8-expressing Vero cells with infectious wild-type viral DNA and a plasmid, pDX, that contains an engineered 780-base-pair (bp) deletion in the ICP8 gene, as well as a spontaneous -55-bp deletion in OriL. Gel electrophoresis and Southern blot analysis indicated that d61 DNA carried both deletions present in pDX. The ability of d61 to replicate despite the deletion in OriL suggested that a functional OriL is not essential for virus replication in vitro. Because d61 harbored two mutations, a second mutant, ts+7, with a deletion in oriL-associated sequences and an intact ICP8 gene was constructed. Both d61 and ts+7 replicated efficiently in their respective permissive host cells, although their yields were slightly lower than those of control viruses with intact oriL sequences.
    [Show full text]
  • Foamy Virus Assembly with Emphasis on Pol Encapsidation
    Viruses 2013, 5, 886-900; doi:10.3390/v5030886 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Review Foamy Virus Assembly with Emphasis on Pol Encapsidation Eun-Gyung Lee 1, Carolyn R. Stenbak 2 and Maxine L. Linial 1,* 1 Fred Hutchinson Cancer Research Center, Basic Sciences Division; 1100 Fairview Avenue North, Seattle, WA 98109, USA; E-Mails: [email protected] (EGL); [email protected] (MLL) 2 Seattle University, Biology Department; 901 12th Avenue, Seattle, WA 98122, USA; E-Mail: [email protected] * Authors to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-206- 667-4442; Fax: +1-206-667-5939 Received: 31 January 2013; in revised form: 11 March 2013 / Accepted: 14 March 2013 / Published: 20 March 2013 Abstract: Foamy viruses (FVs) differ from all other genera of retroviruses (orthoretroviruses) in many aspects of viral replication. In this review, we discuss FV assembly, with special emphasis on Pol incorporation. FV assembly takes place intracellularly, near the pericentriolar region, at a site similar to that used by betaretroviruses. The regions of Gag, Pol and genomic RNA required for viral assembly are described. In contrast to orthoretroviral Pol, which is synthesized as a Gag-Pol fusion protein and packaged through Gag-Gag interactions, FV Pol is synthesized from a spliced mRNA lacking all Gag sequences. Thus, encapsidation of FV Pol requires a different mechanism. We detail how WT Pol lacking Gag sequences is incorporated into virus particles. In addition, a mutant in which Pol is expressed as an orthoretroviral-like Gag-Pol fusion protein is discussed.
    [Show full text]
  • Topological Analysis of the Gp41 MPER on Lipid Bilayers Relevant to the Metastable HIV-1 Envelope Prefusion State
    Topological analysis of the gp41 MPER on lipid bilayers relevant to the metastable HIV-1 envelope prefusion state Yi Wanga,b, Pavanjeet Kaurc,d, Zhen-Yu J. Sune,1, Mostafa A. Elbahnasawya,b,2, Zahra Hayatic,d, Zhi-Song Qiaoa,b,3, Nhat N. Buic, Camila Chilea,b,4, Mahmoud L. Nasre,5, Gerhard Wagnere, Jia-Huai Wanga,f, Likai Songc, Ellis L. Reinherza,b,6, and Mikyung Kima,g,6 aLaboratory of Immunobiology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115; bDepartment of Medicine, Harvard Medical School, Boston, MA 02115; cNational High Magnetic Field Laboratory, Florida State University, Tallahassee, FL 32306; dDepartment of Physics, Florida State University, Tallahassee, FL 32306; eDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115; fDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215; and gDepartment of Dermatology, Harvard Medical School, Boston, MA 02215 Edited by Peter Palese, Icahn School of Medicine at Mount Sinai, New York, NY, and approved September 23, 2019 (received for review July 18, 2019) The membrane proximal external region (MPER) of HIV-1 envelope immunologically vulnerable epitopes targeted by several of the most glycoprotein (gp) 41 is an attractive vaccine target for elicitation of broadly neutralizing antibodies (bNAbs) developed during the broadly neutralizing antibodies (bNAbs) by vaccination. However, course of natural HIV-1 infection (10–13). Insertion, deletion, current details regarding the quaternary structural organization of and mutations of residues in the MPER defined the functional the MPER within the native prefusion trimer [(gp120/41)3] are elu- importance of the MPER in Env incorporation, viral fusion, and sive and even contradictory, hindering rational MPER immunogen infectivity (14–16).
    [Show full text]
  • Allosteric Integrase Inhibitor Potency Is Determined Through the Inhibition of HIV-1 Particle Maturation
    Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation Kellie A. Juradoa, Hao Wanga, Alison Slaughterb, Lei Fengb, Jacques J. Kesslb, Yasuhiro Koha, Weifeng Wanga, Allison Ballandras-Colasa, Pratiq A. Patelc, James R. Fuchsc, Mamuka Kvaratskheliab, and Alan Engelmana,1 aDepartment of Cancer Immunology and AIDS, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA 02215; and bCenter for Retrovirus Research and Comprehensive Cancer Center and cDivision of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH 43210 Edited by Alan R. Rein, National Cancer Institute, Frederick, MD, and accepted by the Editorial Board April 1, 2013 (received for review January 14, 2013) Integration is essential for HIV-1 replication, and the viral integrase HIV-1 preferentially integrates along the bodies of active genes (IN) protein is an important therapeutic target. Allosteric IN inhib- (6), a trait that is largely attributable to an interaction between itors (ALLINIs) that engage the IN dimer interface at the binding site IN and the host protein lens epithelium-derived growth factor for the host protein lens epithelium-derived growth factor (LEDGF)/ (LEDGF)/transcriptional coactivator p75 (reviewed in refs. 7 and transcriptional coactivator p75 are an emerging class of small mole- 8). LEDGF/p75 functions as a bimodal tether during integration: cule antagonists. Consistent with the inhibition of a multivalent drug elements within its N-terminal region confer constitutive binding to target, ALLINIs display steep antiviral dose–response curves ex vivo. chromatin, whereas a downstream IN-binding domain (IBD) binds ALLINIs multimerize IN protein and concordantly block its assembly lentiviral IN proteins (9, 10).
    [Show full text]
  • Patent Document US 06872395
    I 1111111111111111 11111 111111111111111 1111111111 1111111111 lll111111111111111 US006872395B2 (12) United States Patent (10) Patent No.: US 6,872,395 B2 Kawaoka (45) Date of Patent: Mar.29,2005 (54) VIRUSES COMPRISING MUTANT ION Mena, I., et al., "Rescue of a Synthetic Choramphenicol CHANNEL PROTEIN Acetyltransferase RNA into influenza Virus-Like Particles obtained from recombinant plasmids", J. of Virology, vol. (75) Inventor: Yoshihiro Kawaoka, Madison, WI 70, No. 8, XP002150091, 5016-5024, (Aug. 1996). (US) Neumann, G., et al., "Generation of influenza A Viruses entirely from cloned cDNAs", Proc. of the Nat'l Aca. of (73) Assignee: Wisconsin Alumni Research Sciences, USA, vol. 96, XP002150093, 9345-9350, (Aug. Foundation, Madison, WI (US) 1999). ( *) Notice: Subject to any disclaimer, the term of this Neumann, G., et al., "Plasmid-Driven Formation of Influ­ patent is extended or adjusted under 35 enza Virus-Like Particles", J. of Virology, vol. 74, No. 1, U.S.C. 154(b) by O days. XP002150094, 547-551, (Jan. 2000). Neumann, G., et al., "RNA Polymerase I-Mediated Expres­ sion of Influenza Viral RNA Molecules", Virology, vol. 202, (21) Appl. No.: 09/834,095 No. 1, XP000952667, 477-479, (Jul. 1994). (22) Filed: Apr. 12, 2001 Neirynck, S., et al., "A universal influenza A vaccine based on the extracellular domain of the M2 protein", Nature (65) Prior Publication Data Medicine, 5 (10), pp. 1157-1163, (Oct. 1999). US 2003/0194694 Al Oct. 16, 2003 Piller, S. C., et al., "Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid Related U.S. Application Data bilayers", PNAS, 93, pp.
    [Show full text]
  • (Infected Cell Protein 8) of Herpes Simplex Virus L*
    THEJOURNAL OF BIOLOGICAL CHEMISTRY Vol. 262, No. 9, Issue of March 25, pp. 4260-4266, 1987 0 1987 by The American Society of Biological Chemists, Inc Printed in U.S. A. Interaction between theDNA Polymerase and Single-stranded DNA- binding Protein (Infected Cell Protein 8) of Herpes Simplex Virus l* (Received for publication, September 22, 1986) Michael E. O’DonnellS, Per EliasQ,Barbara E. Funnellll, and I. R. Lehman From the Department of Biochemistry, Stanford University School of Medicine, Stanford, California 94305 The herpes virus-encoded DNA replication protein, ICP8 completely inhibits replication of singly primed ssDNA infected cell protein 8 (ICPS), binds specifically to templates by the herpespolymerase. On the other hand, ICP8 single-stranded DNA with a stoichiometry of one ICPS strongly stimulates replication of duplex DNA. It does so, molecule/l2 nucleotides. In the absence of single- however, onlyin the presence of anuclear extract from stranded DNA, it assembles into long filamentous herpes-infected cells. structures. Binding of ICPS inhibits DNA synthesis by the herpes-induced DNA polymerase on singly primed EXPERIMENTALPROCEDURES single-stranded DNA circles. In contrast, ICPS greatly Materials-DNase I and venom phosphodiesterase were obtained stimulates replication of circular duplex DNA by the from Worthington. The syntheticoligodeoxynucleotide (44-mer) was polymerase. Stimulation occurs only in the presence of synthesized by the solid-phase coupling of protected phosphoramidate a nuclear extract from herpes-infected cells. Appear- nucleoside derivatives (11).3H-Labeled #X ssDNA was a gift from ance of the stimulatory activity in nuclear extracts Dr. R. Bryant (this department). pMOB45 (10.5 kilobases) linear coincides closely with the time of appearance of her- duplex plasmid DNA was a gift from Dr.
    [Show full text]
  • The Hepatitis C Virus P7 Protein Forms an Ion Channel That Is Inhibited by Long-Alkyl-Chain Iminosugar Derivatives
    The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives Davor Pavlovic´*, David C. A. Neville*, Olivier Argaud*, Baruch Blumberg†, Raymond A. Dwek*, Wolfgang B. Fischer*, and Nicole Zitzmann*‡ *Department of Biochemistry, University of Oxford, Oxford OX1 3QU, United Kingdom; and †Fox Chase Cancer Center, Philadelphia, PA 19111 Contributed by Baruch Blumberg, March 17, 2003 We show that hepatitis C virus (HCV) p7 protein forms ion channels data have been obtained by introducing mutations into an in black lipid membranes. HCV p7 ion channels are inhibited by infectious cDNA clone of BVDV. An in-frame deletion of the long-alkyl-chain iminosugar derivatives, which have antiviral ac- entire p7 does not affect RNA replication but leads to the tivity against the HCV surrogate bovine viral diarrhea virus. HCV p7 production of noninfectious virions. However, infective viral presents a potential target for antiviral therapy. particles can be generated by complementing p7 in trans (9), which suggests that the pestivirus p7 is essential for the epatitis C virus (HCV) is the major cause of chronic production of infective progeny virus. Interestingly, noninfec- Hhepatitis with a significant risk of end-stage liver cirrhosis tive BVDV particles also are created by treatment with and hepatocellular carcinoma (1). HCV belongs to the family long-alkyl-chain iminosugar derivatives (3). Flaviviridae, which consists of three genera: flaviviruses, pesti- Recently, HCV p7 has been shown to be a polytopic mem- viruses, and hepaciviruses. In the absence of both a suitable small brane protein that crosses the membrane twice and has its N and animal model and a reliable in vitro infectivity assay for HCV, C termini oriented toward the extracellular environment (10).
    [Show full text]
  • An Anti-Cancer Binary System Activated by Bacteriophage HK022 Integrase
    bioRxiv preprint doi: https://doi.org/10.1101/147736; this version posted June 12, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. An anti-cancer binary system activated by bacteriophage HK022 Integrase Amer Elias, Itay Spector1, Natasha Gritsenko, Yael Zilberstein2, Rena Gorovits3, Gali Prag, Mikhail Kolot* Department of Biochemistry and Molecular Biology, Tel-Aviv University, Tel-Aviv 69978, Israel 1 Histospeck, Rishon LeZion PO Box: 75321, Israel 2 Sackler cellular & molecular imaging center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, 69978, Israel 3 Institute of Plant Sciences and Genetics in Agriculture, Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot 76100, Israel *Corresponding author: Mikhail Kolot Tel-Aviv University Department of Biochemistry & Molecular Biology Tel-Aviv 69978 Israel Tel.: +972-3-6406695 Fax: +972-3-6406834 E-mail: [email protected] Key words: DTA toxin, cancer therapy, binary system, site-specific recombination, bacteriophage HK022; Integrase, lung cancer, gene delivery 1 bioRxiv preprint doi: https://doi.org/10.1101/147736; this version posted June 12, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. ABSTRACT Cancer gene therapy is a great promising tool for cancer therapeutics due to the specific targeting based on the cancerous gene expression background. Binary systems based on site- specific recombination are one of the most effective potential approaches for cancer gene therapy.
    [Show full text]
  • Enzyme Activities in Four Different Forms of Human Immunodeficiency
    Proc. Nati. Acad. Sci. USA Vol. 88, pp. 45%-4600, June 1991 Biochemistry Enzyme activities in four different forms of human immunodeficiency virus 1 poi gene products (reverse transcriptase/RNase H/crossover linker mutagenesis/baculoirus expression system) YU-WEN HU AND C. YONG KANG Department of Microbiology and Immunology, University of Ottawa, Faculty of Medicine, Ottawa, ON, Canada K1H 8M5 Communicated by Max D. Summers, February 19, 1991 (received for review December 3, 1990) ABSTRACT Five cassettes of the pol gene of human im- activity (10, 11) but no RNase H activity (3, 7, 12, 13). The munodeficiency virus 1 were constructed and inserted under reverse transcriptase isolated from purified HIV-1 has a the control of the polyhedrin gene promoter of Autographa molecular mass of 95 (14) to 110 (15) kDa, as determined by calfornica nuclear polyhedrosis virus by homologous recom- gel filtration and glycerol gradient centrifugation, respec- bination. The first cassette polF contains the full-length pol tively. However, the 98-kDa nonprocessed polyprotein ex- open reading frame; the second cassette pollOO starts with the pressed in Escherichia coli displayed little or no reverse first AUG codon of the pol gene and deletes 103 amino acids transcriptase activity (16). The p66/pSi heterodimer ex- from the amino terminus of the pol gene product; the third pressed in E. coli has an apparent molecular mass of 120-130 cassette po197 deletes the entire protease coding sequence; the kDa and was active (5, 6). In addition, there is a 165-kDa fourth cassette po166 deletes both the protease and endonucle- putative gag-pol precursor polyprotein that also possesses ase/integrase coding sequences; and the fifth cassette polSl reverse transcriptase activity (10).
    [Show full text]
  • Genomic Diversity in Rotavirus and the Current Scenario of Rotavirus Vaccines: a Brief Overview
    Central Archives of Paediatrics and Developmental Pathology Bringing Excellence in Open Access Review Article *Corresponding author Vijaya Lakshmi Nag, Department of Microbiology, All India Institute of Medical Sciences, Jodhpur, India, Tel: Genomic Diversity in Rotavirus 918003996874; Email: Submitted: 15 October 2017 and the Current Scenario of Accepted: 01 November 2017 Published: 03 November 2017 Copyright Rotavirus Vaccines: A Brief © 2017 Nag et al. Overview OPEN ACCESS Keywords Vijaya Lakshmi Nag* and Kumar Saurabh • Rotavirus infection Department of Microbiology, All India Institute of Medical Sciences, India • Genomic diversity • Rotavirus vaccines Abstract Rotavirus associated infection still dominates the list of diarrheal illnesses in paediatric population despite the availability of effective Rotavirus vaccines. Frequent genetic reassortment in the genome of rotavirus leads to emergence of novel genotypes in different geographic areas worldwide. This review aims to give a brief overview of the genetic diversity prevailing in rotavirus worldwide with a focus on the vaccines available for rotavirus infection. ABBREVIATIONS may also be used. Electron microscopy and polyacrylamide gel electrophoresis are also useful. Molecular techniques like nested RV: Rotavirus Infection; RNA: Ribonucleic Acid; EIA: polymerase chain reaction (PCR), multiplex PCR and Reverse Enzyme Immunoassay; ELISA: Enzyme Linked Immunosorbent transcriptase PCR (RT-PCR) in stool samples can additionally Assay; IgA: Immunoglobulin A; IgG: Immunoglobulin G; PCR: help in the genotypic studies [5-7]. The genetic sequencing Polymerase Chain Reaction; RT-PCR: Reverse Transcriptase PCR; methods like microarray and real time PCR (RT-qPCR) are very VP: Viral Structural Protein; NSP: Non-Structural Protein; PAGE: sensitive methods for diagnosis [8]. Polyacrylamide Gel Electrophoresis; RRV: Rhesus Rotavirus, UIP: Universal Immunization Programme; WHO: World Health Vaccine development and implementation has seen lots of Organization.
    [Show full text]
  • Lentivirus and Lentiviral Vectors Fact Sheet
    Lentivirus and Lentiviral Vectors Family: Retroviridae Genus: Lentivirus Enveloped Size: ~ 80 - 120 nm in diameter Genome: Two copies of positive-sense ssRNA inside a conical capsid Risk Group: 2 Lentivirus Characteristics Lentivirus (lente-, latin for “slow”) is a group of retroviruses characterized for a long incubation period. They are classified into five serogroups according to the vertebrate hosts they infect: bovine, equine, feline, ovine/caprine and primate. Some examples of lentiviruses are Human (HIV), Simian (SIV) and Feline (FIV) Immunodeficiency Viruses. Lentiviruses can deliver large amounts of genetic information into the DNA of host cells and can integrate in both dividing and non- dividing cells. The viral genome is passed onto daughter cells during division, making it one of the most efficient gene delivery vectors. Most lentiviral vectors are based on the Human Immunodeficiency Virus (HIV), which will be used as a model of lentiviral vector in this fact sheet. Structure of the HIV Virus The structure of HIV is different from that of other retroviruses. HIV is roughly spherical with a diameter of ~120 nm. HIV is composed of two copies of positive ssRNA that code for nine genes enclosed by a conical capsid containing 2,000 copies of the p24 protein. The ssRNA is tightly bound to nucleocapsid proteins, p7, and enzymes needed for the development of the virion: reverse transcriptase (RT), proteases (PR), ribonuclease and integrase (IN). A matrix composed of p17 surrounds the capsid ensuring the integrity of the virion. This, in turn, is surrounded by an envelope composed of two layers of phospholipids taken from the membrane of a human cell when a newly formed virus particle buds from the cell.
    [Show full text]
  • 693.Full.Pdf
    Vol. 4, 693-696, Marc/i /998 Clinical Cancer Research 693 Inhibition of Cell Growth and Telomerase Activity of Breast Cancer Cells in Vitro by 3’-Azido-3’-deoxythymidine1 Stella M. Melana, James F. Holland, and target for cancer treatment (9). Recently, the effect of AZT on Beatriz G-T. Pogo2 Chinese hamster ovary cells that display telomerase activity was investigated. AZT was preferentially incorporated into telomeric Department of Medicine, Division of Neoplastic Diseases [S. M. M.. J. F. H.. B. G-T. P.]. and Department of Microbiology [B. G-T. P.]. DNA and Z-DNA-containing regions (2). AZT. alone or in Mount Sinai School of Medicine, New York, New York 10029 combination with other antimetabolites, also inhibited the growth of human bladder cancer and colon cancer cell lines (10). Furthermore, AZT was shown to cause progressive te- ABSTRACT lomere shortening in immortalized B and T human lymphocytic The effect of zidovudine (3’-azido-3’-deoxythymidine; cell lines ( 1 1 ). Taken together. these results have stimulated AZT) was investigated in four breast cancer cell lines, a T4 further research on the effect of AZT on cancer cells. We have, cell leukemia, and a normal breast cell line in vitro. AZT therefore, investigated the effect of AZT on breast cancer cells inhibited the growth of all tumoral cell lines, but it did so in that possess tebomerase activity. The results indicated that AZT a wide range of concentrations. The growth of a normal inhibits breast cancer cell growth. anchorage-independent breast cell line was also inhibited, although it required a growth.
    [Show full text]